Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocotrienol with FOLFOXIRI in Metastatic Colorectal Cancer
NCT02705300Phase 2Completed
- Sponsor
- Vejle Hospital
- Start
- May 2016
- Primary completion
- Aug 2019
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Vejle Hospital. Primary endpoint: Time to first serious adverse event. Started May 2016; status: completed.
Beyond the preview
Go deeper on NCT02705300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02705300.